CUKUROVA MEDICAL JOURNAL, cilt.46, sa.4, ss.1401-1408, 2021 (ESCI)
Purpose: The aim of the present study was to evaluate survivin immunoexpression and the clinicopathologic correlations in serous borderline ovarian tumors (BOT) patients <= 40 years old.